Looks like you have JavaScript disabled. For the full Twine experience, you will need to re-enable it.

Supply chain and programme director with 15+ years leading end-to-end operations, including 12 years across pharma, biotech and medtech. I lead complex manufacturing networks through major change - ERP deployments, 3PL transitions, network redesign and global planning transformations, while keeping teams grounded with a clear direction and people-first execution. I have built and scaled supply chain operating models (S&OE, S&OP and IBP), improved patient and customer delivery performance, and delivered measurable outcomes in working capital, inventory reduction and stock availability. I’m a straightforward, influence-led leader who builds capability across people, process and technology to create resilient supply chains.…Supply chain and programme director with 15+ years leading end-to-end operations, including 12 years across pharma, biotech and medtech. I lead complex manufacturing networks through major change - ERP deployments, 3PL transitions, network redesign and global planning transformations, while keeping teams grounded with a clear direction and people-first execution. I have built and scaled supply chain operating models (S&OE, S&OP and IBP), improved patient and customer delivery performance, and delivered measurable outcomes in working capital, inventory reduction and stock availability. I’m a straightforward, influence-led leader who builds capability across people, process and technology to create resilient supply chains.

AMY POLLITT





Supply chain and programme director with 15+ years leading end-to-end operations, including 12 years across pharma, biotech and medtech. I lead complex manufacturing networks through major change - ERP deployments, 3PL transitions, network redesign and global planning transformations, while keeping teams grounded with a clear direction and people-first execution. I have built and scaled supply chain operating models (S&OE, S&OP and IBP), improved patient and customer delivery performance, and delivered measurable outcomes in working capital, inventory reduction and stock availability. I’m a straightforward, influence-led leader who builds capability across people, process and technology to create resilient supply chains.…Supply chain and programme director with 15+ years leading end-to-end operations, including 12 years across pharma, biotech and medtech. I lead complex manufacturing networks through major change - ERP deployments, 3PL transitions, network redesign and global planning transformations, while keeping teams grounded with a clear direction and people-first execution. I have built and scaled supply chain operating models (S&OE, S&OP and IBP), improved patient and customer delivery performance, and delivered measurable outcomes in working capital, inventory reduction and stock availability. I’m a straightforward, influence-led leader who builds capability across people, process and technology to create resilient supply chains.

Available to hire

Supply chain and programme director with 15+ years leading end-to-end operations, including 12 years across pharma, biotech and medtech. I lead complex manufacturing networks through major change - ERP deployments, 3PL transitions, network redesign and global planning transformations, while keeping teams grounded with a clear direction and people-first execution.

I have built and scaled supply chain operating models (S&OE, S&OP and IBP), improved patient and customer delivery performance, and delivered measurable outcomes in working capital, inventory reduction and stock availability. I’m a straightforward, influence-led leader who builds capability across people, process and technology to create resilient supply chains.

Skills

Experience Level

Expert

Expert

Intermediate

Intermediate

Beginner

Language

English

Fluent

Work Experience

Senior Director, Global Supply Chain (Biotech/Rare Disease) at Amicus Therapeutics

March 2, 2023 - December 31, 2024

Led supply chain readiness for commercial launches across the US, UK, EU and international markets. Owned end-to-end global supply chain in a highly constrained, patient-critical rare disease setting. Established S&OE to stabilise supply, sharpen execution and enable scalable decision-making. Redesigned global S&OP to improve enterprise alignment and executive visibility. Built performance framework and KPIs to support earlier, data-led decisions. Led global teams spanning supply chain, digital and process excellence; received the 2023 CEO Distinguished Excellence Award for leadership and impact.

Head of Global Supply Chain Planning at AstraZeneca Pharmaceuticals

January 1, 2022 - December 31, 2023

Led planning for a $10bn+ revenue portfolio and 30bn standard manufacturing units, achieving 99% stock availability. Led global and regional teams across EMEA, Americas and APAC, including Global Planning Directors. Designed and implemented therapeutic-area S&OP, aligning VPs across manufacturing, commercial, portfolio and finance.

EMEA Asset Planning Director at AstraZeneca Pharmaceuticals

January 1, 2020 - December 31, 2022

Led EMEA COVID-19 supply response, protecting patient supply through severe disruption; received a CEO Award for impact. Partnered with Regional VPs and Plant Directors to improve supply chain performance.

Global Planning Transformation Programme Director at AstraZeneca Pharmaceuticals

January 1, 2020 - December 31, 2022

Designed and led a new global planning operating model affecting more than 250 roles; recognized by the Executive Team as one of the largest supply chain transformations in a decade and described as world-class. Led consultation with unions in close partnership with HR. Built and led the Regional Change Champion network to strengthen ownership of programme milestones and deadlines. Delivered a 10% cost reduction.

Programme Director – Supply Chain Segmentation at AstraZeneca Pharmaceuticals

January 1, 2017 - December 31, 2020

Designed and implemented global segmentation strategy across 27 production sites and 140 markets. Eliminated stock-outs in the most strategic segment and maintained stock availability above 99%. Supported double-digit growth through supply assurance, improved productivity by 20%, and increased supply chain transparency and quality of trade-off decisions.

Global External Procurement, Asset Planning Lead at AstraZeneca Pharmaceuticals

January 1, 2014 - December 31, 2017

Improved supplier performance and cross-enterprise working. Designed and implemented supplier S&OP and capacity planning for the external supply network. Led a team of Supply Chain Managers across Europe and the US, responsible for tactical supply performance.

Senior Logistics Manager / Supply Chain Manager at Tata Steel

January 1, 2010 - December 31, 2014

Led large-scale warehouse and transport operations.